Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Cutaneous Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC
- Status
- TERMINATED
- Phase
- PHASE2
Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
High-Risk Skin Cancers With Atezolizumab Plus NT-I7
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
CemiplimAb Survivorship Epidemiology
- Status
- COMPLETED
- Phase
- N/A
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Expanded Access Protocol for Cemiplimab in Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
New Strategies Against Cutaneous Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Treatment With Nab-paclitaxel in Cutaneous SCC
- Status
- TERMINATED
- Phase
- PHASE2
Microarray Analysis of microRNA Expression Profiles in Cutaneous Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A